title: [Myxoma syndrome].
abstract: The paper provides the follow-up findings of patients with cardiac myxomas according to the presence or absence of the myxomal syndrome. It is shown that it is a multiorgan abnormality wherein the cardiac myxomas that are prone to primarily multiple growth, extraseptal and/or multifocal fixation are associated with the changes in the hypothalamus-pituitary-adrenal and renin-angiotensin-aldosterone systems, skin spotty pigmentation, neoplasms in the viscera, skin, and fat. These specific features emphase the predictive value of the myxomal syndrome, which predetermines that its early diagnosis should be made in routine clinical practice.
authors.forename: B A
authors.initials: BA
authors.lastname: Konstantinov
authors.forename: M A
authors.initials: MA
authors.lastname: Nechaenko
authors.forename: L I
authors.initials: LI
authors.lastname: Vinnitskiĭ
authors.forename: S A
authors.initials: SA
authors.lastname: Kabanova
mesh_terms: D015062:11-Hydroxycorticosteroids / Q000097:blood; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006338:Heart Neoplasms / Q000097:blood / Q000601:surgery*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008875:Middle Aged; D009232:Myxoma / Q000097:blood / Q000601:surgery*; D011182:Postoperative Care; D011237:Predictive Value of Tests; D011300:Preoperative Care; D012084:Renin-Angiotensin System; D013577:Syndrome
chemical_list: D015062:11-Hydroxycorticosteroids; D014408:Biomarkers, Tumor; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone